DCM VI, L.P. 4
4 · Augmedix, Inc. · Filed Oct 7, 2020
Insider Transaction Report
Form 4
Augmedix, Inc.NONE
DCM VI, L.P.
Director10% Owner
Transactions
- Award
Common Stock
2020-10-05+3,064,751→ 3,064,751 total - Purchase
Common Stock
2020-10-05$3.00/sh+666,667$2,000,001→ 3,731,418 total - Award
Common Stock
2020-10-05+20,007→ 20,007 total(indirect: See footnote) - Award
Warrant (right to buy)
2020-10-05+269,490→ 269,490 totalExercise: $2.88Exp: 2029-09-02→ Common Stock (269,490 underlying)
Footnotes (4)
- [F1]On October 5, 2020, the Issuer's wholly-owned subsidiary, August Acquisition Corp. ("Acquisition Sub"), merged with and into Augmedix, Inc., a privately held Delaware corporation ("Augmedix"). Pursuant to this transaction (the "Merger"), Augmedix was the surviving corporation and became the Issuer's wholly owned subsidiary. All of the outstanding shares of stock of Augmedix held by accredited investors were converted into shares of the Issuer's common stock. All of the outstanding warrants, options and stock appreciation rights of Augmedix were assumed by the Issuer.
- [F2]These securities are held of record by DCM VI, L.P. ("DCM VI"). Jason Krikorian, a member of the Issuer's board of directors, is a general partner at DCM, which is an affiliate of DCM VI.
- [F3]These securities are held of record by A-Fund, L.P. ("A-Fund"). Jason Krikorian, a member of the Issuer's board of directors, is a general partner at DCM, which is an affiliate of A-Fund.
- [F4]The warrants are fully vested and exerciseable.